Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Peter Kolchinsky
AddedMar 31, 2024
UpdatedMay 31, 2026
Peter Kolchinsky

Peter Kolchinsky

Board Member, ARS Pharmaceuticals

Crunchbase

Peter Kolchinsky's Career

ARS Pharmaceuticals
ARS Pharmaceuticals

San Diego, CA, US

Board Member· Board
Antera Therapeutics
Antera Therapeutics

Boston, MA, US

Board Member· Board
Medeor Therapeutics
Medeor Therapeutics

San Mateo, CA, US

Board Member· Board
Lantos Technologies
Lantos Technologies

Wilmington, MA, US

Board Member· Board
Zipline Medical
Zipline Medical

Campbell, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Peter Kolchinsky's Career

ARS Pharmaceuticals
ARS Pharmaceuticals
Public$75M532015San Diego, CA, US
Board Member· Board

Leadership at ARS Pharmaceuticals

Pratik ShahPratik ShahBoard Member
Richard LowenthalRichard LowenthalCo-Founder & CEO
Peter ThompsonPeter ThompsonBoard Member
Laura ShawverLaura ShawverBoard Member
Michael KellyMichael KellyBoard Member
Saqib IslamSaqib IslamBoard Member

Similar to ARS Pharmaceuticals

Bryn PharmaBryn PharmaBeverly Hills, CA, USPharmaceuticalsest. 2017Bryn PharmaBeverly Hills, CA, US · est. 2017

Bryn Pharma: Providing easy-to-use, portable nasal epinephrine for anaphylaxis treatment.

Series B · $125.2M5
Amphastar PharmaceuticalsAmphastar PharmaceuticalsRancho Cucamonga, CA, USBiologics, Pharmaceuticalsest. 1996Amphastar PharmaceuticalsRancho Cucamonga, CA, US · est. 1996

Amphastar Pharmaceuticals: A leading US-based specialty pharma company, expert in developing injectable and inhalation products.

Public · $300M1.6k
AktivaxAktivaxAurora, CO, USDrug Deliveryest. 2008AktivaxAurora, CO, US · est. 2008

Aktivax innovates drug delivery tech for emergencies, offering robust auto-injectors with extended shelf life.

Angel · $515.3k7
AdrenaCardAdrenaCardMinneapolis, MN, USMedical Devicesest. 2014AdrenaCardMinneapolis, MN, US · est. 2014

AdrenaCard: Integrating life-saving drugs with user-friendly devices for easy carry.

Angel · $1M5
Antera Therapeutics
Antera Therapeutics
Seed$2.3M302014Boston, MA, US
Board Member· Board

Similar to Antera Therapeutics

Anthera PharmaceuticalsAnthera PharmaceuticalsHayward, CA, USPharmaceuticalsest. 2004Anthera PharmaceuticalsHayward, CA, US · est. 2004

Anthera Pharmaceuticals: A US biopharma firm specializing in inflammation and autoimmune disease treatments.

Public · $101.5M21
Enanta PharmaceuticalsEnanta PharmaceuticalsWatertown, MA, USDrugs, Pharmaceuticalsest. 1995Enanta PharmaceuticalsWatertown, MA, US · est. 1995

US-based Enanta Pharmaceuticals develops small molecule drugs for viral infections and liver diseases.

Public · $84.6M160
Ansata TherapeuticsAnsata TherapeuticsSan Diego, CA, USTopical Drugsest. 2002Ansata TherapeuticsSan Diego, CA, US · est. 2002

Ansata Therapeutics Inc., a US-based biopharmaceutical company, specializes in developing topical drugs.

Series B · $2.5M30
Aria PharmaceuticalsAria PharmaceuticalsPalo Alto, CA, USPharmaceuticalsest. 2014Aria PharmaceuticalsPalo Alto, CA, US · est. 2014

Aria Pharmaceuticals: Pioneering novel therapies for complex diseases in preclinical stages.

Series B · $14.3M38
Medeor Therapeutics
Medeor Therapeutics
Series B$75.8M102012San Mateo, CA, US
Board Member· Board

Leadership at Medeor Therapeutics

Steven DeitcherSteven DeitcherBoard Member
Frank KungFrank KungBoard Member
Giovanni FerraraGiovanni FerraraCEO
Cp LiuCp LiuBoard Member
Anand MehraAnand MehraBoard Member
Wei LiWei LiBoard Member

Similar to Medeor Therapeutics

Tract TherapeuticsTract TherapeuticsChicago, IL, USMedicalest. 2013Tract TherapeuticsChicago, IL, US · est. 2013

Nova Biomedical: Innovating immune balance restoration for solid organ transplant patients.

Series B · $15M5
LTZ TherapeuticsLTZ TherapeuticsSan Francisco, CA, USImmunotherapy, Therapeuticsest. 2022LTZ TherapeuticsSan Francisco, CA, US · est. 2022

LTZ: Innovating immunotherapies for cancer and diseases with unmet clinical needs.

Seed · $27M16
Meditope BiosciencesMeditope BiosciencesPasadena, CA, USCancer Therapeuticsest. 2011Meditope BiosciencesPasadena, CA, US · est. 2011

Meditope Biosciences: Biotech firm specializing in antibody-based cancer treatments.

Series A · $3.6M6
SpheringenicsSpheringenicsAtlanta, GA, USCell Therapiesest. 2007SpheringenicsAtlanta, GA, US · est. 2007

SpherIngenics: Leading biotech firm specializing in innovative cell-based medicinal therapies.

Pre-Seed · $730k4
Lantos Technologies
Lantos Technologies
Series A$31.8M362009Wilmington, MA, US
Board Member· Board

Similar to Lantos Technologies

Wavs CustomWavs CustomGreenville, SC, USAudio Devices, Earphonesest. 2020Wavs CustomGreenville, SC, US · est. 2020

WAVS Custom: Innovating music tech with custom-fit earphones via patented 3D scanning.

Angel · $1.4M1
PionEar TechnologiesPionEar TechnologiesAllston-Brighton, MA, USMedical Devicesest. 2018PionEar TechnologiesAllston-Brighton, MA, US · est. 2018

PionEar Technologies: Innovating medical devices for ear and hearing disorders.

Angel · $50k10
XinVivoXinVivoMorrisville, NC, US3D Scanning, Medical Devicesest. 2015XinVivoMorrisville, NC, US · est. 2015

XinVivo: A nanotech firm specializing in medical devices and 3D scanning technology.

Series B · $25.3M30
Cactus MedicalCactus MedicalIrvine, CA, USMedical Devicesest. 2017Cactus MedicalIrvine, CA, US · est. 2017

Cactus: Innovating healthcare with 98% accurate, non-invasive ear infection detection for physicians and home use.

Pre-Seed · $1.2M3
Zipline Medical
Zipline Medical
Series F$56M112007Campbell, CA, US
Board Member· Board

Leadership at Zipline Medical

Ted DriscollTed DriscollBoard Member
Bali MuralidharBali MuralidharBoard Member
Stephen ReedersStephen ReedersBoard Member
Amir BelsonAmir BelsonFounder
John TigheJohn TigheBoard Member
Dean TozerDean TozerBoard Member

Peter Kolchinsky's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Peter Kolchinsky

Bob KocherBob KocherBoard Member · Virta HealthNathanael GrayNathanael GrayBoard Member · C4 TherapeuticsHoward PalefskyHoward PalefskyBoard Member · Avantis Medical SystemsPeter S. KrausPeter S. KrausBoard Member · AXAJason GrahamJason GrahamBoard Member · Golden Angels InvestorsPhilip KantoffPhilip KantoffBoard Member · Memorial Sloan Kettering Cancer Center